Skip to main content

New Products: NanoInk's NanoArray Assay System


NanoInk this week launched its NanoArray Assay System for the automated analysis of its protein NanoArray assays.

According to the Skokie, Ill.-based firm, the system enables the detection, identification, and quantitation of clinically relevant, low abundance proteins from a wide variety of sample types for applications such as biomarker analysis, translational medicine, and toxicology.

The desktop unit can create reproducible protein arrays over millimeter areas and then can fluorescently image these arrays with 0.5 nanometer resolution, according to the firm.

The company also claims that the platform can achieve sub-picogram sensitivities with 2 nanoliters or less of sample.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.